Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes

Journal of Reproductive Immunology

Volumn 79, Issue 2, 2009, Pages 188-195

  Yamada, Hideto ^a   Atsumi, Tatsuya ^a   Kobashi, Gen ^b   Ota, Chikako ^c   Kato, Emi H ^a   Tsuruga, Noriko ^a   Ohta, Kaori ^b   Yasuda, Shinsuke ^a   Koike, Takao ^a   Minakami, Hisanori ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Antiphospholipid antibody; Fetal growth restriction; Fetal loss; Pregnancy induced hypertension; Premature delivery

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KININOGEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADVERSE OUTCOME; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; LOW DRUG DOSE; MATERNAL AGE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; NONHUMAN; PARITY; PREDICTOR VARIABLE; PREECLAMPSIA; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THROMBOEMBOLISM;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS;

EID: 61849105454     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2008.11.001     Document Type: Article

References (35)

1. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. 77 (2002) 67-75
2. Atsumi T., Ieko M., Bertolaccini M.L., Ichikawa K., Tsutsumi A., Matsuura E., and Koike T. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum. 43 (2000) 1982-1993
3. Balada E., Ordi-Ros J., Paredes F., Villarreal J., Mauri M., and Vilardell-Tarres M. Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. Scand. J. Rheumatol. 30 (2001) 235-241
4. Branch D.W., Porter T.F., Rittenhouse L., Caritis S., Sibai B., Hogg B., Lindheimer M.D., Klebanoff M., MacPherson C., VanDorsten J.P., Landon M., Paul R., Miodovnik M., Meis P., and Thurnau G. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Antiphospholipid antibodies in women at risk for preeclampsia. Am. J. Obstet. Gynecol. 184 (2001) 825-834
5. Detkova D., Gil-Aguado A., Lavilla P., Cuesta M.V., Fontan G., and Pascual-Salcedo D. Do antibodies to beta2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?. Lupus 8 (1999) 430-438
6. Dreyfus M., Hedelin G., Kutnahorsky R., Lehmann M., Viville B., Langer B., Fleury A., M'Barek M., Treisser A., Wiesel M.L., and Pasquali J.L. Antiphospholipid antibodies and preeclampsia: a case-control study. Obstet. Gynecol. 97 (2001) 29-34
7. Faden D., Tincani A., Tanzi P., Spatola L., Lojacono A., Tarantini M., and Balestrieri G. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 73 (1997) 37-42
8. Gris J.C., Quere I., Sanmarco M., Boutiere B., Mercier E., Amiral J., Hubert A.M., Ripart-Neveu S., Hoffet M., Tailland M.L., Rousseau O., Monpeyroux F., Dauzat M., Sampol J., Daures J.P., Berlan J., and Marès P. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study-NOHA. Thromb. Haemost. 84 (2000) 228-236
9. Guo Y.L., and Colman R.W. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off. J. Thromb. Haemost. 3 (2005) 670-676
10. Harris E.N., Gharavi A.E., Patel S.P., and Hughes G.R. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin. Exp. Immunol. 68 (1987) 215-222
11. Hayashi I., Amano H., Yoshida S., Kamata K., Kamata M., Inukai M., Fujita T., Kumagai Y., Furudate S., and Majima M. Suppressed angiogenesis in kininogen-deficiencies. Lab. Invest. 82 (2002) 871-880
12. Katano K., Aoki K., Sasa H., Ogasawara M., Matsuura E., and Yagami Y. beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum. Reprod. 11 (1996) 509-512
13. Kesmodel U., Wisborg K., Olsen S.F., Henriksen T.B., and Secher N.J. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol. 37 (2002) 87-92
14. Lain K.Y., and Roberts J.M. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287 (2002) 3183-3186
15. Lee E.Y., Lee C.K., Lee T.H., Chung S.M., Kim S.H., Cho Y.S., Yoo B., and Moon H.B. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?. Thromb. Res. 111 (2003) 29-32
16. Lee R.M., Brown M.A., Branch D.W., Ward K., and Silver R.M. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet. Gynecol. 102 (2003) 294-300
17. Lindbohm M.L., Sallmen M., and Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health. Scand. J. Work Environ. Health 28 Suppl. 2 (2002) 84-96
18. Lynch A., Byers T., Emlen W., Rynes D., Shetterly S.M., and Hamman R.F. Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy. Obstet. Gynecol. 93 (1999) 193-198
19. Majima M., Mizogami S., Kuribayashi Y., Katori M., and Oh-ishi S. Hypertension induced by a nonpressor dose of angiotensin II in kininogen-deficient rats. Hypertension 24 (1994) 111-119
20. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H., De Groot P.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., and Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4 (2006) 295-306
21. Ness R.B., Grisso J.A., Hirschinger N., Markovic N., Shaw L.M., Day N.L., and Kline J. Cocaine and tobacco use and the risk of spontaneous abortion. N. Engl. J. Med. 340 (1999) 333-339
22. Obermoser G., Bitterlich W., Kunz F., and Sepp N.T. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb. Haemost. 90 (2003) 108-115
23. Obermoser G., Bitterlich W., Kunz F., and Sepp N.T. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies. Int. Arch. Allergy Immunol. 135 (2004) 148-153
24. Pattison N.S., Chamley L.W., McKay E.J., Liggins G.C., and Butler W.S. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br. J. Obstet. Gynaecol. 100 (1993) 909-913
25. Poole J.H. Aggressive management of HELLP syndrome and eclampsia. AACN Clin. Issues 8 (1997) 524-538
26. Sanmarco M., Alessi M.C., Harle J.R., Sapin C., Aillaud M.F., Gentile S., Juhan-Vague I., and Weiller P.J. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses. Thromb. Haemost. 85 (2001) 800-805
27. Sanmarco M., Gayet S., Alessi M.C., Audrain M., de Maistre E., Gris J.C., de Groot P.G., Hachulla E., Harlé J.R., Sié P., and Boffa M.C. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. Thromb. Haemost. 97 (2007) 949-954
28. Sugi T., Katsunuma J., Izumi S., McIntyre J.A., and Makino T. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil. Steril. 71 (1999) 1060-1065
29. Sugi T., Matsubayashi H., Inomo A., Dan L., and Makino T. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss. J. Obstet. Gynaecol. Res. 30 (2004) 326-332
30. Van Pampus M.G., Dekker G.A., Wolf H., Huijgens P.C., Koopman M.M., von Blomberg B.M., and Buller H.R. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am. J. Obstet. Gynecol. 180 (1999) 1146-1150
31. Von Tempelhoff G.F., Heilmann L., Spanuth E., Kunzmann E., and Hommel G. Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-syndrome. Hemolysis, elevated liver-enzymes, low platelets. Thromb. Res. 100 (2000) 363-365
32. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris E.N., Hughes G.R., Triplett D.A., and Khamashta M.A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42 (1999) 1309-1311
33. Windham G.C., Fenster L., Hopkins B., and Swan S.H. The association of moderate maternal and paternal alcohol consumption with birthweight and gestational age. Epidemiology 6 (1995) 591-597
34. Yamada H., Atsumi T., Kato E.H., Shimada S., Morikawa M., and Minakami H. Prevalence of diverse antiphospholipid antibodies in women with recurrent spontaneous abortion. Fertil. Steril. 80 (2003) 1276-1278
35. Yasuda M., Takakuwa K., Tokunaga A., and Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet. Gynecol. 86 (1995) 555-559